Cardioprotective effect of resveratrol analogue isorhapontigenin versus omega-3 fatty acids in isoproterenol-induced myocardial infarction in rats

Journal of Physiology and Biochemistry

Volumn 72, Issue 3, 2016, Pages 469-484

  Abbas, Amr M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Inflammatory markers; Isorhapontigenin; Myocardial infarction; Omega 3 fatty acids; Oxidative stress

Indexed keywords

CATALASE; CREATINE KINASE MB; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; ISOPRENALINE; ISORHAPONTIGENIN; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; OMEGA 3 FATTY ACID; PHOSPHOLIPID; RESVERATROL; STILBENE DERIVATIVE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIOXIDANT; AUTACOID; BIOLOGICAL MARKER; CARDIOTONIC AGENT; LIPID; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAM; ENZYME BLOOD LEVEL; HEART INFARCTION; HEART PROTECTION; HISTOPATHOLOGY; LIPID BLOOD LEVEL; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; R WAVE AMPLITUDE; RAT; RAT MODEL; ST SEGMENT ELEVATION; ADVERSE EFFECTS; ANIMAL; BLOOD; CARDIAC MUSCLE; COMPARATIVE STUDY; DIETARY SUPPLEMENT; DISEASE MODEL; HEART; LIPID PEROXIDATION; METABOLISM; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; BIOMARKERS; CARDIOTONIC AGENTS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; HEART; INFLAMMATION MEDIATORS; ISOPROTERENOL; LIPID PEROXIDATION; LIPIDS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; STILBENES;

EID: 84969760158     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-016-0494-4     Document Type: Article

References (41)

1. Adkins Y, Kelley DS (2010) Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem 21:781–792
2. Baumann KH, Hessel F, Larass I et al (1999) Dietary -3, -6 and -9 unsaturated fatty acids and growth factor and cytokine gene expression in unstimulated and stimulated monocytes. Arterioscler Thromb Vasc Biol 19:59–66
3. Bosch J, Gerstein HC, Dagenais GR et al (2012) N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 367(4):309–318
4. Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, Ashton T, Zotos PC, Haboubi NA, Elwood PC (2003) Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 57:193–200
5. Chen YR, Yi FF, Li XY, Wang CY, Chen L, Yang XC, Su PX, Cai JR (2008) Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction. Cardiovasc Drugs Ther 22:479–485
6. Connor WE (2000) Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 71:171S–175S
7. Cosar M, Songur A, Sahin O, Uz E, Yilmaz R, Yagmurca M et al (2008) The neuroprotective effect of fish n-3 fatty acids in the hippocampus of diabetic rats. Nutr Neurosci 11:161–166
8. El-Gendy AA, Abbas AM (2014) Effect of omega-3 fatty acids on haemostatic functions in urocortin-treated obese rats. J Physiol Biochem 70:809–820
9. Eleawa SM, Alkhateeb M, Ghosh S, Al-Hashem F, Shatoor AS, Alhejaily A, Khalil MA (2015) Coenzyme Q10 protects against acute consequences of experimental myocardial infarction in rats. Int J Physiol Pathophysiol Pharmacol 7(1):1–13
10. Fernández-Marín MI, Guerrero RF, García-Parrilla MC, Puertas B, Richard T, Rodriguez-Werner MA, Winterhalter P, Monti JP, Cantos-Villar E (2012) Isorhapontigenin: a novel bioactive stilbene from wine grapes. Food Chem 135:1353–1359
11. Fox KAA, Steg PG, Eagle KA et al (2007) Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA 297(17):1892–1900
12. Hirafuji M, Machida T, Hamaue N, Minami M (2003) Cardiovascular protective effects of n-3 polyunsaturated fatty acids with special emphasis on docosahexaenoic acid. J Pharmacol Sci 92:308–316
13. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ et al (2006) Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. Br Med J 332:752–760
14. Kang JX, Xiao YF, Leaf A (1995) Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A 92:3997–4001
15. Kareem MA, Krushna GS, Hussain SA, Devi KL (2009) Effect of aqueous extract of nutmeg on hyperglycaemia, hyperlipidaemia and cardiac histology associated with isoproterenol-induced myocardial infarction in rats. Trop J Pharm Res 8(4):337
16. Karthikeyan K, Bai BRS, Devaraj SN (2007) Efficacy of grape seed proanthocyanidins on serum and heart tissue lipids in rats subjected to isoproterenol-induced myocardial injury. Vascul Pharmacol 47:295–301
17. Kawakami S, Kinoshita Y, Maruki-Uchida H, Yanae K, Sai M, Ito T (2014) Piceatannol and its metabolite, isorhapontigenin, induce SIRT1 expression in THP-1 human monocytic cell line. Nutrients 6:4794–4804
18. Khalil MI, Tanvir EM, Afroz R, Sulaiman SA, Gan SH (2015) Cardioprotective effects of tualang honey: amelioration of cholesterol and cardiac enzymes levels. BioMed Research International. Volume 2015, Article ID 286051
19. Kromhout D, Giltay EJ, Geleijnse JM, Alpha Omega Trial Group (2010) n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 363:2015–2026
20. Li H, Wang A, Huang Y et al (2005) Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Free Radic Biol Med 38(2):243–257
21. Lin JF, Lin SM, Chih CL, Nien MW, Su HH, Hu BR, Huang SS, Tsai SK (2008) Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats. Life Sci 83:313–317
22. Lobo Filho HG, Ferreira NL, de Sousa RB, de Carvalho ER, Dantas Lobo PL, Lobo Filho JG (2011) Experimental model of myocardial infarction induced by isoproterenol in rats. Rev Bras Cir Cardiovasc 26(3):469–476
23. London B, Albert C, Anderson ME, Giles WR, Van Wagoner DR, Balk E, Billman GE, Chung M, Lands W, Leaf A, McAnulty J, Martens JR, Costello RB, Lathrop DA (2007) Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research. Circulation 116:e320–e335
24. Murugesan M, Manju V (2012) Effect of luteolin on lipid peroxidation and antioxidants in acute and chronic periods of isoproterenol induced myocardial infarction in rats. J Acute Med 2:70–76
25. Nounou HA, Deif MM, Shalaby MA (2012) Effect of flaxseed supplementation and exercise training on lipid profile, oxidative stress and inflammation in rats with myocardial ischemia. Lipids Health Dis 11:129
26. Osadchii OE, Norton GR, McKechnie R, Deftereos D, Woodiwiss AJ (2007) Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic β-adrenoreceptor activation. Am J Physiol Heart Circ Physiol 292(4):H1898–H1905
27. Ozen OA, Cosar M, Sahin O, Fidan H, Eser O, Mollaoglu H et al (2008) The protective effect of fish n-3 fatty acids on cerebral ischemia in rat prefrontal cortex. Neurol Sci 29:147–152
28. Patel V, Upaganlawar A, Zalawadia R, Balaraman R (2010) Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation. Eur J Pharmacol 644(1–3):160–168
29. Pervaiz S, Holme AL (2009) Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal 11(11):2851–2897
30. Priscilla DH, Prince PSM (2009) Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats. Chem Biol Interact 179:118–124
31. Radhiga T, Rajamanickam C, Senthil S, Pugalendi KV (2012) Effect of ursolic acid on cardiac marker enzymes, lipid profile and macroscopic enzyme mapping assay in isoproterenol-induced myocardial ischemic rats. Food Chem Toxicol 50(11):3971–3977
32. Rallidis LS, Paschos G, Papaioannou ML et al (2004) The effect of diet enriched with α-linolenic acid on soluble cellular adhesion molecules in dyslipidaemic patients. Atherosclerosis 174:127–132
33. Ramesh CV, Malarvannan P, Jayakumar R, Jayasundar S, Puvanakrishnan R (1998) Effect of a novel tetrapeptide derivative in a model of isoproterenol induced myocardial necrosis. Mol Cell Biochem 187:173–182
34. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS (2012) Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events. JAMA 308:1024–1033
35. Rona G (1985) Catecholamine cardiotoxicity. J Mol Cell Cardiol 17:291–306
36. Rustan AC, Nossen JO, Christiansen EN, Drevon CA (1988) Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyl-transferase. J Lipid Res 29:1417–1426
37. Saravanan G, Ponmurugan P, Sathiyavathi M, Vadivukkarasi S, Sengottuvelu S (2013) Cardioprotective activity of Amaranthus viridis Linn: effect on serum marker enzymes, cardiac troponin and antioxidant system in experimental myocardial infarcted rats. Int J Cardiol 165(3):494–498
38. Sharmila ST, Rajadurai M (2012) Preventive effect of Bio-Aq on cardiac markers, lipids, and membrane bound enzymes in isoproterenol-induced myocardial infarction in rats. Asian J Pharm Clin Res 5(2):107–113
39. Upaganlawar A, Gandhi C, Balaraman R (2009) Effect of green tea and vitamin E combination in isoproterenol induced myocardial infarction in rats. Plant Foods Hum Nutr 64:75–80
40. Wang H, Yang Y, Zhang H, Yan H, Wu X, Zhang C (2014) Administration of the resveratrol analogues isorhapontigenin and heyneanol-a protects mice hematopoietic cells against irradiation injuries. BioMed Research International. Volume 2014: Article ID 282657
41. Wang QL, Lin M, Liu GT (2001) Antioxidative activity of natural isorhapontigenin. Jpn J Pharmacol 87:61–66